
PharmaCyte Biotech
PharmaCyte Biotech: A California-based biotech firm specializing in live-cell encapsulation for cancer and diabetes treatments.
- 281.3k
- Public company
- Las Vegas, NV, USUnited States
PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer, diabetes and malignant ascites based on its Cell-in-a-Box live-cell encapsulation technology.
Its cancer therapy encapsulates genetically engineered human cells that convert an inactive chemotherapy drug into its active cancer-killing form. For pancreatic cancer, the encapsulated cells are implanted in the blood supply near the tumor and ifosfamide is given intravenously at one-third the normal dose.
Similar Companies

Photonpharma
photonpharma.net

Encellin
encellin.com

SymbioCellTech
symbiocelltech.com
MonarchBio
monarch-bio.com
Bio Green Med Solution
cyclacel.com

Iovance Biotherapeutics
iovance.com

Pact Pharma

Cage Pharma
cagephar.ma

Cell BioEngines
cellbioengines.com

Cello Therapeutics
cellothera.com

OmniCyte
omnicyte.com

Xcell Biosciences
xcellbio.com

Bellicum Pharmaceuticals

Ernexa Therapeutics
eternatx.com

Cartesian Therapeutics

Thunder Biotech
thunderbiotech.com

Celularity
celularity.com
International Stem Cell

Umoja Biopharma

Cel-Sci
cel-sci.com
Quick Facts
Who are PharmaCyte Biotech's competitors?
Companies similar to PharmaCyte Biotech include Photonpharma, Encellin, SymbioCellTech and MonarchBio.
When was PharmaCyte Biotech founded?
PharmaCyte Biotech was founded in 1996.
Where is PharmaCyte Biotech's headquarters located?
PharmaCyte Biotech's headquarters is located in Las Vegas, NV, US.
When was PharmaCyte Biotech's last funding round?
PharmaCyte Biotech's most recent funding round was for $70M (USD) in August 2021.
How much disclosed funding has PharmaCyte Biotech raised?
As of Aug 19, 2021, PharmaCyte Biotech has disclosed funding of $87.1M (USD). Undisclosed round amounts are excluded.
How many employees does PharmaCyte Biotech have?
PharmaCyte Biotech has 281,269 employees as of Feb 5, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Revenue
- Customer
- Main Product
- Tags
- Also Known As
- PharmaCyte Biotech, Inc.
- Headquarters
- 3960 Howard Hughes Parkway
- Suite 500
- Las Vegas, NV, 89169
- US
- Ticker
- PMCB
- SEC CIK
- 0001157075
- EIN
- 62-1772151
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2836Biological Products, Except Diagnostic Substances
- 2800Chemicals And Allied Products
- 2830Drugs
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 19 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325411Medicinal and Botanical Manufacturing
- 325414Biological Product (except Diagnostic) Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2833Medicinal Chemicals And Botanical Products
- 2870Agricultural Chemicals
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research